Sushma Verma

Dr. Sushma Verma


Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2024 in Current Drug Delivery
Verified
Journal Article
Closed access
PDF file
SSSakshi Saharawat
Sakshi Saharawat
SVSushma Verma
Sushma Verma
: Niosomes are newly developed, self-assembling sac-like transporters that deliver medication at a specific site in a focused manner, increasing availability in the body and prolonging healing effects. Niosome discovery has increased drugs’ therapeutic effectiveness while also reducing adverse effects. : This article aims to concentrate on the increase in the worldwide utilization of niosomal formulation. This overview presents a thorough perspective of niosomal investigation up until now, encompassing categories and production techniques, their significance in pharmaceutical transportation, and cosmetic use. : The thorough literature review revealed that extensive attention has been given to developing nanocarriers for drug delivery as they hold immense endeavor to attain targeted delivery to the affected area simultaneously shielding the adjacent healthy tissue. Many reviews and research papers have been published that demonstrate the interest of scientists in niosomes. Phytoconstituents, which possess antioxidant, antibiotic, anti-inflammatory, wound healing, anti-acne, and skin whitening properties, are also encapsulated into niosome. Their flexibility allows for the incorporation of various therapeutic agents, including small molecules, proteins, and peptides making them adaptable for different types of drugs. Niosomes can be modified with ligands, enhancing their targeting capabilities. : A flexible drug delivery mechanism provided by non-ionic vesicles, which are self-assembling vesicular nano-carriers created from hydrating non-ionic surfactant, cholesterol, or amphiphilic compounds along comprehensive applications such as transdermal and brain-targeted delivery.

20 July 2022 in International journal of health sciences
Verified
Journal Article
Open access
PDF file
SASyed Akhlaque Ahmed
Syed Akhlaque Ahmed
SVSushma Verma
Sushma Verma
SKSuhail Khan
Suhail Khan
ASAlka Sharma
Alka Sharma
Topical delivery of drugs is one of the ideal routes of administrating a wide range of drug candidates and emulgels are emerging as a novel formulation, which exhibited the characteristics of both the emulsions and gels. Emulgel demonstrated improved penetrability during several studies and it is able to deliver hydrophilic as well as hydrophobic drugs and hence overcome the limitations of traditionally available topical preparations. More stable and effective emulgels can be prepared by nanonizing and micronizing the globules of emulsions, which improves the stability and half-life of Emulgels. The commercial availability along with the presence of strong clinical pipeline of emulgels is indicating towards the acceptance of this formulation while several advantages associated with this approach is also suggesting towards its potential as ideal topical drug delivery system. This article enlisted in-depth information about the emulgels, its components and structure along with the general method of production, evaluation and future scenario of this approach. The article also involved information about the patents insight, commercially available products and previously used drugs for developing stable emulgels.

1 February 2025 in Recent Patents on Nanotechnology
Verified
Journal Article
Closed access
PDF file
SSSakshi Saharawat
Sakshi Saharawat
SVSushma Verma
Sushma Verma
Niosomes are novel, self-assembled vesicular carriers that deliver both lipophilic and hydrophilic drugs at the specific site in a targeted way, enhancing bioavailability and extending therapeutic effects. Niosomes are a versatile drug delivery system with a diverse range of applications from gene to brain-targeted delivery and they are more attractive choices than liposomes as they are efficient at biodegrading. Niosome offers several advantages over conventional drug delivery systems, including enhanced stability, and also have gained a lot of focus in natural product delivery in recent years. This review provides a comprehensive view of niosomal research and recent advancements, including classification and fabrication methods, and their role in drug delivery and targeting. The description of the rise in niosomal formulation patents around the world is also elaborated along with the natural product delivery of niosomes which has recently gained significance. Patents on novel preparation, loading, and modification techniques have enhanced the importance of niosome in the pharmaceutical industry.

20 July 2022 in International journal of health sciences
Verified
Journal Article
Open access
PDF file
SASyed Akhlaque Ahmed
Syed Akhlaque Ahmed
SVSushma Verma
Sushma Verma
SKSuhail Khan
Suhail Khan
ASAlka Sharma
Alka Sharma
Topical delivery of drugs is one of the ideal routes of administrating a wide range of drug candidates and emulgels are emerging as a novel formulation, which exhibited the characteristics of both the emulsions and gels. Emulgel demonstrated improved penetrability during several studies and it is able to deliver hydrophilic as well as hydrophobic drugs and hence overcome the limitations of traditionally available topical preparations. More stable and effective emulgels can be prepared by nanonizing and micronizing the globules of emulsions, which improves the stability and half-life of Emulgels. The commercial availability along with the presence of strong clinical pipeline of emulgels is indicating towards the acceptance of this formulation while several advantages associated with this approach is also suggesting towards its potential as ideal topical drug delivery system. This article enlisted in-depth information about the emulgels, its components and structure along with the general method of production, evaluation and future scenario of this approach. The article also involved information about the patents insight, commercially available products and previously used drugs for developing stable emulgels.

22 June 2022 in International journal of health sciences
Verified
Journal Article
Open access
PDF file
ASAlka Sharma
Alka Sharma
SVSushma Verma
Sushma Verma
SKSuhail Khan
Suhail Khan
SASyed Akhlaque Ahmed
Syed Akhlaque Ahmed
It is well known that certain medications suffer hepatic first-pass metabolism or deteriorate in the digestive system, the buccal drug delivery method may be an alternative to oral administration. Because it is painless and may be swiftly and readily removed if the treatment must be terminated or interrupted, the buccal mucosa has long been ideal for administering medications. This paper focuses on the buccal drug delivery system had the goal of gathering recent literature and presenting a concise explanation of buccal patches by discussing the characteristics of an ideal mucoadhesive system, benefits of buccal delivery and disadvantages thereof, factors affecting buccal absorption, and various types of patches as well as the preparation method and composition thereof. The compilation of the data is also enhanced by adding market products as well as the patented, so that reader will get the complete knowledge about the buccal drug delivery.

1 May 2025 in Reviews on Recent Clinical Trials
Verified
Journal Article
Closed access
PDF file
VBVikash Singh Bhadouria
Vikash Singh Bhadouria
SVSushma Verma
Sushma Verma
CAChhaya Agarwal
Chhaya Agarwal
DSDeep Shikha Sharma
Deep Shikha Sharma
Gout, an inflammatory arthritis form, is renowned for its historical association with affluence. This review delves into its pathophysiology, exploring hyperuricemia, urate crystal formation, and the ensuing inflammatory response. The epidemiology of gout is examined, focusing on its rising prevalence and impact on public health. In this study, progress in gout management is discussed, involving pharmacological interventions, dietary changes, and emerging therapies. Genetic predisposition and triggers like alcohol, temperature, and diet are highlighted in this study. Prevention strategies, including serum urate-lowering therapy and lifestyle modifications, aim to reduce recurrent flares and complications. The inflammatory response in acute gout attacks is elucidated, involving immune cells, cytokines, and the NLRP3 inflammasome. Chronic gout manifestations, such as gouty tophus formation, are explored for their destructive impact on surrounding tissues. Recent advancements in gout treatment, including nanotherapies and novel compounds, are discussed, along with promising urate-lowering drugs. Cutting-edge research on zinc ferrite nanoparticles, dimethyl fumarate, and myricetin/nobiletin hybrids addresses oxidative stress and inflammation in gout. Additionally, the potential therapeutic role of methanolic leaf extract of Euphorbia milii and tip-loaded CLC-Soluplus® MAPs is explored as natural and transdermal alternatives for gout management. The review also covers the development status of new urate-lowering drugs, providing insights into promising candidates and their mechanisms. Patents on gout and recent diagnostic advancements using techniques like laser confocal micro Raman spectrometer, FTIR, and THz-TDS offer a more accurate approach for gout stone analysis, enabling early detection and targeted treatment.